ruleID	txid	organism	gene	nodeID	protein accession	HMM accession	nucleotide accession	ARO accession	mutation	variation type	gene context	drug	drug class	phenotype	clinical category	breakpoint	breakpoint standard	breakpoint condition	PMID	evidence code	evidence grade	evidence limitations	rule curation note
PSA0001	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	amikacin	-	wildtype	S	(MIC <= 16 mg/L)	EUCAST v15.0 (2025)	breakpoint in brackets, i.e. not to be used for monotherapy	11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619).MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0002	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	amikacin	-	wildtype	S	(MIC <= 16 mg/L)	EUCAST v15.0 (2025)	breakpoint in brackets, i.e. not to be used for monotherapy	11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619).MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0003	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	amoxicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  (3493236)	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0004	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	amoxicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0005	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	amoxicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0006	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	amoxicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0007	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	amoxicillin-clavulanic acid	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  (3493236), 2158496, 2159863	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence, ECO:0000024 protein-binding evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0008	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	amoxicillin-clavulanic acid	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0009	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	amoxicillin-clavulanic acid	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0010	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	amoxicillin-clavulanic acid	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0011	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ampicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  (3493236)	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0012	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	ampicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0013	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	ampicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0014	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	ampicillin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0015	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ampicillin-sulbactam	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  (3493236), 2159863	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence, ECO:0000024 protein-binding evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0016	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	ampicillin-sulbactam	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0017	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	ampicillin-sulbactam	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0018	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	ampicillin-sulbactam	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0019	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	aztreonam	-	wildtype	I	MIC <= 16 mg/L	EUCAST v15.0 (2025)	-	9925544	ECO:0001091 knockout phenotypic evidence	high	-	ampC (blaPDC) derepression occurs by the acquistion of mutations in its major regulators genes: ampD (10681322, 16251318, 16641450), dacB (19325877) and ampR (27736752, 29029112). Leads to acquired resistance
PSA0020	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	aztreonam	-	wildtype	I	MIC <= 16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0021	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	aztreonam	-	wildtype	I	MIC <= 16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0022	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	aztreonam	-	wildtype	I	MIC <= 16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0023	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	11083635	ECO:0001091 knockout phenotypic evidence	high	-	ampC (blaPDC) derepression occurs by the acquistion of mutations in its major regulators genes: ampD (10681322, 16251318, 16641450), dacB (19325877) and ampR (27736752, 29029112). Leads to acquired resistance
PSA0024	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0025	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0026	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619). MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0027	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619). MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0028	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	cefepime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0029	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	cefotaxime	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  3493236	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0030	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	cefotaxime	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0031	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	cefotaxime	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0032	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	cefotaxime	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0033	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ceftazidime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	9925544,  3493236	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) derepression occurs by the acquistion of mutations in its major regulators genes: ampD (10681322, 16251318, 16641450), dacB (19325877) and ampR (27736752, 29029112). Leads to acquired resistance
PSA0034	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	ceftazidime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0035	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	ceftazidime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0036	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	ceftazidime	-	wildtype	I	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0037	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ceftazidime-avibactam	-	wildtype	S	MIC <= 8 mg/L	EUCAST v15.0 (2025)	-	9925544,  3493236	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	Mutations in the omega loop region of AmpC (specific  blaPDC alleles) are associated with acquisition of resistance to the BL-BLI combinations ceftolozane-tazobactam and ceftazidime-avibactam.  
PSA0038	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ceftolozane-tazobactam	-	wildtype	S	MIC <= 4 mg/L	EUCAST v15.0 (2025)	-	(9925544),  (3493236), 2158496, 2159863	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence, ECO:0000024 protein-binding evidence	high	-	Mutations in the omega loop region of AmpC (specific  blaPDC alleles) are associated with the acqusition of  resistance to the BL-BLI combinations ceftolozane-tazobactam and ceftazidime-avibactam.  
PSA0039	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	ceftriaxone	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9925544,  (3493236)	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0040	287	s__Pseudomonas aeruginosa	catB7	catB7	AAD02068.1	-	-	ARO:3002679	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	10361706	ECO:0000005 enzymatic activity assay evidence	low	lacks evidence of the degree to which MIC is affected	Species has expected resistance to chloramphenicol, and catB7 has demonstrated activity as a chloramphenicol acetyltransferase. However knockout mutants suggest the driver of clinical resistance is efflux via MexAB pump and the presence of catB7 in the absence of MexAB is unlikely to confer clinical resistance.
PSA0041	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0042	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0043	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	11083635, 12483565	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	low	lacks evidence of the degree to which MIC is affected	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY).  Species has expected resistance to chloramphenicol, and MexXY has demonstrated activity for chloramphenicol. However knockout mutants suggest the driver of clinical resistance is efflux via MexAB pump and the presence of MexXY in the absence of MexAB is unlikely to confer clinical resistance.
PSA0044	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	11083635, 12483565	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	low	lacks evidence of the degree to which MIC is affected	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY).  Species has expected resistance to chloramphenicol, and MexXY has demonstrated activity for chloramphenicol. However knockout mutants suggest the driver of clinical resistance is efflux via MexAB pump and the presence of MexXY in the absence of MexAB is unlikely to confer clinical resistance.
PSA0045	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0046	287	s__Pseudomonas aeruginosa	mexE	mexE	AAG05881.1, CAK15125.1	NF045904.1	-	ARO:3000803	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	low	lacks evidence of the degree to which MIC is affected	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators. All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0047	287	s__Pseudomonas aeruginosa	mexF	-	AAG05882.1	-	-	ARO:3000804	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	low	lacks evidence of the degree to which MIC is affected	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators. All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0048	287	s__Pseudomonas aeruginosa	oprN	-	AAG05883.1	-	-	ARO:3000805	-	Gene presence detected 	core	chloramphenicol	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	low	lacks evidence of the degree to which MIC is affected	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators. All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0049	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms are needed to reach clinical resistance.  MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0050	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms are needed to reach clinical resistance.  MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0051	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0052	287	s__Pseudomonas aeruginosa	crpP	crpP	AEQ93536.1	-	-	ARO:3004467	-	Gene presence detected 	acquired	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	34001507	ECO:0000005 enzymatic activity assay evidence	high	-	CrpP Is Not a Fluoroquinolone-Inactivating Enzyme
PSA0053	287	s__Pseudomonas aeruginosa	mexE	mexE	AAG05881.1, CAK15125.1	NF045904.1	-	ARO:3000803	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0054	287	s__Pseudomonas aeruginosa	mexF	-	AAG05882.1	-	-	ARO:3000804	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0055	287	s__Pseudomonas aeruginosa	oprN	-	AAG05883.1	-	-	ARO:3000805	-	Gene presence detected 	core	ciprofloxacin	-	wildtype	I	MIC <=0.5 mg/L	EUCAST v15.0 (2025)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0056	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	ertapenem	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0057	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	ertapenem	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0058	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	ertapenem	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0059	287	s__Pseudomonas aeruginosa	fosA_PA1129	fosA_PA1129	-	NF000094.1	-	ARO:3000149	-	Gene presence detected 	core	fosfomycin	-	wildtype	S	MIC <= 256 mg/L	ECOFF (January 2024)	-	28851843	ECO:0000012 functional complementation evidence	high	-	
PSA0060	287	s__Pseudomonas aeruginosa	aph(3')-IIb	aph(3')-IIb	AGY72832.1, CAA62365.1	-	-	ARO:3002645	-	Gene presence detected 	core	kanamycin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	6307974, 14638496	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence, ECO:0000005 enzymatic activity assay evidence	high	-	
PSA0061	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	kanamycin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	10543738, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0062	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	kanamycin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	10543738, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0063	287	s__Pseudomonas aeruginosa	crpP	crpP	AEQ93536.1	-	-	ARO:3004467	-	Gene presence detected 	acquired	levofloxacin	-	wildtype	I	MIC <=2 mg/L	EUCAST v15.0 (2025)	-	34001507	ECO:0000005 enzymatic activity assay evidence	high	-	CrpP Is Not a Fluoroquinolone-Inactivating Enzyme
PSA0064	287	s__Pseudomonas aeruginosa	blaOXA-50_fam	blaOXA-50_fam	-	NF000432.2	-	ARO:3001796	-	Gene presence detected 	core	meropenem	-	wildtype	S	MIC <= 8 mg/L	EUCAST v15.0 (2025)	Non-meningitis	15155197, 26621621	ECO:0000012 functional complementation evidence	high	-	blaOXA-50 is a chromosomally encoded _-lactamase, also known as PoxB. Increases carbapenem MICs when overexpressed in vitro, but contribution to intrinsic resistance, if any, is marginal
PSA0065	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	meropenem	-	wildtype	S	MIC <= 8 mg/L	EUCAST v15.0 (2025)	Non-meningitis	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0066	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	meropenem	-	wildtype	S	MIC <= 8 mg/L	EUCAST v15.0 (2025)	Non-meningitis	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms are needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0067	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	meropenem	-	wildtype	S	MIC <= 8 mg/L	EUCAST v15.0 (2025)	Non-meningitis	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	MexAB-OprM overexpression contributes to increased MICs  to this antibiotic but additional resistance mechanisms are needed to reach clinical resistance. MexAB-OprM overexpression occurs by the acquistion of mutations in its major regulators genes: mexR (8878574), nalC ( 15387820) and nalD (15855496).
PSA0068	287	s__Pseudomonas aeruginosa	aph(3')-IIb	aph(3')-IIb	AGY72832.1, CAA62365.1	-	-	ARO:3002645	-	Gene presence detected 	core	neomycin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	6307974, 14638496	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence, ECO:0000005 enzymatic activity assay evidence	high	-	
PSA0069	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	norfloxacin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0070	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	norfloxacin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0071	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	norfloxacin	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0072	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	piperacillin	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	9925544,  3493236, 2158496, 2159863	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence	high	-	ampC (blaPDC) expression is inducible by certain _-lactams (especially cefoxitin (3149885) and imipenem (3929679)), induction requires a functional AmpR (9118225). 
PSA0073	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	piperacillin	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0074	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	piperacillin	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0075	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	piperacillin	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0076	287	s__Pseudomonas aeruginosa	blaPDC_gen	blaPDC_gen	-	-	-	ARO:3000098	-	Gene presence detected 	core	piperacillin-tazobactam	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	(9925544),  (3493236), 2158496, 2159863	ECO:0001091 knockout phenotypic evidence, ECO:0000005 enzymatic activity assay evidence, ECO:0000024 protein-binding evidence	high	-	ampC (blaPDC) derepression occurs by the acquistion of mutations in its major regulators genes: ampD (10681322, 16251318, 16641450), dacB (19325877) and ampR (27736752, 29029112). Leads to acquired resistance
PSA0077	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	piperacillin-tazobactam	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0078	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	piperacillin-tazobactam	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0079	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	piperacillin-tazobactam	-	wildtype	I	MIC <=16 mg/L	EUCAST v15.0 (2025)	-	8540696, 11083635, 12483565, 9925544	ECO:0001091 knockout phenotypic evidence	high	-	
PSA0080	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	sulfamethoxazole	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0081	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	sulfamethoxazole	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0082	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	sulfamethoxazole	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0083	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	tetracycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0084	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	tetracycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0085	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	tetracycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0086	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	tetracycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	10543738, 10952562, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0087	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	tetracycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	10543738, 10952562, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0088	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	tigecycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	12604529	ECO:0001091 knockout phenotypic evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0089	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	tigecycline	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	12604529	ECO:0001091 knockout phenotypic evidence	high	-	MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0090	287	s__Pseudomonas aeruginosa	mexX	mexX	BAA34299.1, AAF14522.1	-	-	ARO:3003034	-	Gene presence detected 	core	tobramycin	-	wildtype	S	MIC <= 2 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	10543738, 11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance.  MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619). MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0091	287	s__Pseudomonas aeruginosa	mexY	-	BAA34300.1	-	-	ARO:3003033	-	Gene presence detected 	core	tobramycin	-	wildtype	S	MIC <= 2 mg/L	EUCAST v15.0 (2025)	Uncomplicated urinary tract infection	10543738, 11083635	ECO:0001091 knockout phenotypic evidence	high	-	MexXY overexpression contributes to increased MICs to this antibiotic but additional resistance mechanisms might be needed to reach clinical resistance.  MexXY overexpression occurs by the acquistion of mutations in its major regulator gene mexZ (15336398) or within ParRS (21149619). MexXY requires a functional OprM (9925549). All components of the efflux-pump system need to be functional (MexX-MexY)
PSA0092	287	s__Pseudomonas aeruginosa	mexA	mexA	AAA74436.1	NF033834.1	-	ARO:3000377	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0093	287	s__Pseudomonas aeruginosa	mexB	-	AAA74437.1	-	-	ARO:3000378	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0094	287	s__Pseudomonas aeruginosa	oprM	-	AAG03816.1	-	-	ARO:3000379	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	8226684, 8540696, 11083635, 12483565	ECO:0001091 knockout phenotypic evidence	high	-	All components of the efflux-pump system need to be functional (MexA-MexB-OprM)
PSA0095	287	s__Pseudomonas aeruginosa	mexE	mexE	AAG05881.1, CAK15125.1	NF045904.1	-	ARO:3000803	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0096	287	s__Pseudomonas aeruginosa	mexF	-	AAG05882.1	-	-	ARO:3000804	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).
PSA0097	287	s__Pseudomonas aeruginosa	oprN	-	AAG05883.1	-	-	ARO:3000805	-	Gene presence detected 	core	trimethoprim	-	wildtype	R	not applicable	EUCAST Expected Resistant Phenotypes v1.2 (2023)	-	9044268	ECO:0001091 knockout phenotypic evidence, ECO:0000012 functional complementation evidence	high	-	MexEF-OprN overexpression contributes to increased MICs to this antibiotic. MexEF overexpression occurs by the acquistion of mutations in its regulators All components of the efflux-pump system need to be functional (MexE-MexF-OprN).